Through dual‐luciferase assays, SMAD2 and TAB2 were confirmed as downstream targets of miR‐155‐5p, regulating the PCa cellular phenotype governed by miR‐155‐5p. This evidence concerns the gene SMAD2 and posterior cortical atrophy.